Dottoressa Sara De Carolis

Professore aggregato presso il Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

Dottoressa Sara De CarolisLa Dottoressa Sara De Carolis è professore aggregato presso il Dipartimento Scienze della Salute della Donna e del Bambino presso la Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma. Su BimbiSanieBelli.it risponde a dubbi e domande su ginecologia, gravidanza e ostetricia.

La sua scheda al Policlino Gemelli
Il suo curriculum universitario

Se non trovi la risposta al tuo quesito, fai la tua domanda ai nostri specialisti. Ti risponderemo prima possibile. Fai una domanda all’esperto

Il Curriculum Vitae della dottoressa Sara De Carolis

TITOLI CONSEGUITI
– Laurea in Medicina e Chirurgia presso l’Università Cattolica del S. Cuore di Roma il 2/11/1982, con voto 110/110 e Lode
– Abilitazione all’esercizio della professione di Medico Chirurgo nel Dicembre 1982, presso l’Università Cattolica del S. Cuore di Roma
– Iscrizione all’Ordine dei Medici della provincia di Ascoli Piceno dal Dicembre 1982
– Specializzazione nel luglio 1986 in Ginecologia ed Ostetricia, presso l’Università Cattolica del S. Cuore di Roma, con voto 70/70 e Lode, discutendo la tesi: “Deficit congenito di antitrombina III in gravidanza”

– Ricercatore Confermato Settore: MED/40 GINECOLOGIA E OSTETRICIA settore concorsuale: 06/H1 dal 1Giugno 1998

– Professore Aggregato (UCSC) dall’anno accademico 2007-08

– Abilitazione Scientifica Nazionale 2012 a Professore di II fascia per la disciplina di GINECOLOGIA ED OSTETRICIA (Risultati ASN 2012 Settore 06/H1: Abilitato) con validità Abilitazione dal 02/01/2014 al 02/01/2020

Qualifiche professionali
– Specialista in Ginecologia ed Ostetricia nel 1982, presso l’Università Cattolica del S. Cuore di Roma, con voto 70/70 e Lode
– Ha avviato nel 1988/1989 con il Prof. Pierpaolo Mastroiacovo dell’Istituto di Pediatria dell’Università Cattolica del S. Cuore (UCSC) il servizio del “Telefono Rosso”, un servizio di informazione per i fattori di rischio in gravidanza
– Nominata Medico Interno Universitario con Compiti Assistenziali (MIUCA) nell’Istituto di Ginecologia ed Ostetricia (UCSC) nel Febbraio1988, Ottobre 1988-Dicembre 1988 e ininterrottamente dal 1 Aprile 1989 fino al 31 Maggio 1998
– Ricercatore Universitario presso l’Istituto di Clinica Ostetrica e Ginecologica (UCSC) con decorrenza dal 1 giugno 1998 a tutt’oggi
– Dirigente Medico di I Livello presso la Divisione di Patologia Ostetrica e Ginecologia del Policlinico A. Gemelli dal 1 Giugno 1998 ad oggi

-Incarico di Responsabile dell’Unità Operativa Semplice (UOS) “Malattie internistiche in gravidanza” presso l’U.O.C. Patologia Ostetrica e Ginecologica, afferente al Dipartimento per la tutela della donna e della vita nascente dal 01/04/2010 al 28/02/2018

– Incarico di Alta Specializzazione mell’ambito dell’Unità Operativa Complessa “Patologia Ostetrica” di durata triennale dal 1 Gennaio 2017

– Dal 2003 al 2005 ha effettuato una collaborazione con la Deloitte Consulting, per un progetto denominato “Benchmarking sui percorsi assistenziali ginecologici-ostetrici” con le Cliniche Ostetriche ed le Divisioni dell’ospedale San Paolo della Fondazione Centro San Raffaele del monte Tabor, del Fatebenefratelli Macedonio Melloni di Milano e dell’Ospedale Sant’Anna di Ferrara. I risultati del progetto sono illustrati nel volume “Benchmarking Percorsi Assistenziali in Ostetricia e Ginecologia” (2005 Poletto Editore)

– Valutatore dei progetti, e delle attività di referaggio dell’Università degli studi di Padova (Magnifico Rettore Giuseppe Zaccaria) dal 16 Febbraio 2011

– Commissione di Dottorato: in Fisiopatologia della Riproduzione Umana dell’Università degli studi di Bari (Bari 2003); in Scienze mediche, Cliniche sperimentali dell’Università degli studi di Padova (Padova 2012); ed
– Revisore MIUR dal 27 marzo 2012

– Incarico di Responsabile del “Polo Donna”, servizio volto alla definizione di percorsi clinici, eventi, protocolli, procedure, audit etc. presso il Policlinico Gemelli, attività svolta dal 16/05/2013 al 31/01/2016

– Responsabile del servizio “Fiocchi in ospedale”, presso il Policlinico Gemelli una collaborazione con “Save the Children”, un servizio di assistenza alla maternità con disagio sociale e psichico, dal attivo dal 2015 al 2017

 

PREMI

Vincitrice del XXIII Premio A. Gemelli, quale miglior Laureata in Medicina e Chirurgia per l’anno 1982, avendo conseguito a tutti gli esami del corso di Laurea una votazione pari a 30/30 con 16 Lodi

Vincitrice di un Premio di perfezionamento post-universitario dell’Ente Kirner nel 1984

Vincitrice di Borsa di studio con concorso nazionale del Ministero della Pubblica Istruzione, per la frequenza alla scuola di Specializzazione in Ginecologia ed Ostetricia 1982-1986

Vincitrice del Premio per il miglior Poster presentato al Congresso: “International Symposium on Perinatal Nutrition and Brain Development”. Troina, 21-24 Novembre, 1993 (premio in lire 3.400.000)

Vincitrice Premio S.I.D.I.P 2011 per il lavoro scientifico “Pre-pregnant body mass index (BMI) in women with gestational diabetes mellitus (GDM9 and pregnancy outcome”, Roma 26-28 Ottobre 2011 (premio in euro 1500,00)

Vincitrice Premio Fondazione Giorgio Pardi come coautore con il lavoro scientifico “False positive IgM for CMV in pregnant women with autoimmune disease: a prognostic index of poor pregnancy outcome”. Congresso Agorà SIMP (Società Italiana di Medicina Perinatale) Milano, 27-29 nov 2014

Vincitrice nel 2015 della Borsa di studio della Conferenza Episcopale Italiana con progetto di ricerca triennale dal Titolo “Studio Prospettico sul Ruolo di Fattori Infettivi in Gravidanza Complicate da Malattie Autoimmuni” (tutor della dott.ssa Sara Tabacco)

– “Premio Pubblicazioni di alta qualità’“, anno 2017 Linea PREMIO da parte dell’Ufficio Ricerca dell’Università Cattolica S. Cuore per la pubblicazione (Responsabile): “The impact of primary Sjogren syndrome on pregnancy outcome: our series and review of the literature” De Carolis s et al, Autoimmunity Reviews, 2014; 13 (2): 103-107 (Euro 3013,00)

– “Premio Pubblicazioni di alta qualità’“, anno 2017 Linea PREMIO da parte dell’Ufficio Ricerca dell’Università Cattolica S. Cuore per la pubblicazione (Co-autore): “Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature” Autoimmunity Reviews, 2017; 16 (4): 427-432 (Euro 3013,00)

– “Premio Pubblicazioni di alta qualità’“, anno 2018 Linea PREMIO da parte dell’Ufficio Ricerca dell’Università Cattolica S. Cuore per la pubblicazione (Responsabile) “ Is there any role for the Hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?” Autoimmunity Reviews, 2015; Sep;14 (9):760-2 (Euro 3063,00)

 

RICONOSCIMENTI

– L’articolo “Emergency cerclage in the presence of protruding membranes: is pregnancy outcome predictable?” Caruso A, Trivellini C, De Carolis S, Paradisi G, Mancuso S, Ferrazzani S è stato selezionato dalla rivista “Obstetrical and Gynecological Survey” 672-673, Nov 2000

– L’articolo “Uterine myomectomy in pregnant women”. De Carolis S, Fatigante G, Ferrazzani S, Trivellini C, De Santis L, Mancuso S, Caruso A. Caruso A, Trivellini C, De Carolis S, Paradisi G, Mancuso S, Ferrazzani S. Acta Obstet Gynecol Scand. 2000 Apr;79(4):265-8 è stato selezionato dalla rivista “Obstetrical and Gynecological Survey” 450-451, Aug 2001

-L’articolo “Pregnancy Outcome and Total Parenteral Nutrition in Malnourished Pregnant Women” Caruso, Alessandro; De Carolis, Sara; Ferrazzani, Sergio; Trivellini, Carmen; Mastromarino, Carmen; Pittiruti, Mauro è stato selezionato dalla rivista “Obstetrical and Gynecological Survey” 85-87, feb 1999

– L’articolo “Maternal neonatal vitamin K deficiency secondary to maternal biliopancreatic diversion ; Bersani I, De Carolis MP, Salvi S, Zecca E, Romagnoli C, De Carolis S. Blood Coagul Fibrinolysis. 2011 Jun;22 (4):334-6 è stato selezionato dalla rivista online DocGuide Weekly (Gynaecology/Obstetrics), 2011

– Articolo “The impact of primary Sjogren’s syndrome on pregnancy outcome: Our series and review of the literature” De Carolis S, Salvi S, Botta A, Garofalo S, Garufi C, Ferrazzani S, De Carolis MP Autoimmun Rev. 2014 Feb;13 (2):103 – segnalato su MDLinx.com come tra i primi 10 articoli più letti

– Articolo scelto quale “Highlighted Article” della rivista Autoimmunity Reviews per il mese di Settembre 2015 per l’articolo: “Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?” S. De Carolis et al Autoimmunity Reviews, Volume 14, Issue 9, September 2015, Pages 760–762

– Articolo scelto quale “Highlighted Article” della rivista Autoimmunity Reviews per il mese di Settembre 2018 per l’articolo: “Antiphospholipid syndrome: An update on risk factors for pregnancy outcome. De Carolis S, et al. Autoimmun Rev. 2018 Oct;17(10):956-966. doi: 10.1016/j.autrev.2018.03.018. Epub 2018 Aug 15

Articolo scelto da Mendeley@notifications.elsevier.com “Antiphospholipid syndrome: An update on risk factors for pregnancy outcome. De Carolis S, et al. Autoimmun Rev. 2018 Oct;17(10):956-966. doi: 10.1016/j.autrev.2018.03.018. Epub 2018 Aug 15

– Selezionato per il “Global Specialty Channel for peer discussion and collaboration” dal G-Med specialist, the Global Physicians Online Network

-Invito alla Cerimonia di conferimento del 58° Premio Gemelli per i migliori laureati dell’Università Cattolica, per porgere una testimonianza in qualità di vincitore del Premio Gemelli 1983, Milano 26 Novembre 2018.

 

COLLABORAZIONI NAZIONALI

  1. Dipartimento della Salute della Donna e del Bambino; Reumatologia, Anestesiologia, Allergologia, Neurologia, Dipartimento di Scienze Mediche; Ematologia, Anatomia Patologica, Igiene, Dipartimento di Medicina Interna, Gastroenterologia, Endocrinologia e Diabetologia; Fisiopatologia respiratoria; Cardiologia, Cardiochirurgia; Divisione di Chirurgia Endocrina; Istituto di Biochimica; Istituto di Clinica Chirurgica, Istituto di Semeiotica Medica; Università Cattolica del Sacro Cuore, Roma
  2. Dipartimento di Ginecologia, Ostetricia e Urologia; of Human Biotechnology and Hematology; Dipartimento di Reumatologia; Dipartimento di Medicina Interna e Specialità Mediche; Dipartimento di Biotecnologia ed Ematologia,”Sapienza” Università di Roma, Roma
  3. Dipartimento di Neonatologia medica e chirurgica, Cardiochirurgia, Cardiologia, Ospedale Pediatrico Bambino Gesù, Roma
  4. Clinica Ostetrica Ospedale San Paolo della Fondazione Centro San Raffaele del monte Tabor, Fatebenefratelli Macedonio Melloni di Milano, Milano
  5. Ostetricia dell’Ospedale Sant’Anna, Ferrara
  6. Centro Polimedico per la Prevenzione dell’Aborto Spontaneo Ricorrente, Roma
  7. Unità di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale; Unità di Cardiologia, Dipartimento di Scienze Cardiache, Toraciche e Vascolari; Centro delle Trombosi; Università di Padova, Padova
  8. Unità di Ginecologia e Ostetricia, Neonatologia e Unità di Terapia Intensiva Neonatologica, Reumatologia ed Immunologia Clinica, Dipartmento delle Scienze Cliniche e Sperimentale, Spedali Civili, Università di Brescia, Brescia
  9. Unità Di Reumatologia, Università di Pisa, Pisa
  10. Department of Medicine, Surgery and Neuroscience, Rheumatology Unit, Università di Siena, Siena
  11. Dipartimento di Ostetricia e Ginecologia, Università di Torino, Torino
  12. Unità di Allergologia e Immunologia, Department of Clinical Immunology, A.O. Ospedale Mauriziano, Torino
  13. Dipartmento di Ostetricia e Ginecologia, Dipartimento di Medicina Interna, Università-Ospedale Sant’Anna, Torino
  14. Divisione of Reumatologia, Department of Clinical Sciences and Community Health, Medicina Interna, Università di Milano, Milano
  15. Ostetricia e Neonatologia; Pregnancy and Rheumatic Diseases Clinic; Laboratorio Autoimmunità e Inflammazione Vascolare; Unit of Medicine and Clinical Immunology; Allergologia e Immunologia Clinica, U.O. Medicina ad indirizzo Immunlogico Clinico; Autoimmunità e inflammazione vascolare; Unità di Reumatologia, Medicina ed Immunologia Clinica; IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milano
  16. Istituto di Ostetricia e Ginecologia, Pediatria, Fondazione Policlinico Mangiagalli, Milano, Dipartimento di Medicina Interna e Reumatologia, Ospedale Niguarda, Milano
  17. Division of Rheumatology, G. Pini Institute, Milano
  18. Dipartmento di Clinical Sciences and Community Health, Università di Milano, Milano
  19. Istituto Auxologico IRCCS, Milano
  20. Divisione di Reumatologia, IRCCS Policlinico S. Matteo, Pavia
  21. Dipartimento di Ostetricia e Ginecologia, Università of Pavia, Pavia
  22. Pediatria, Ospedale G. Panico, Tricase
  23. Atherosclerosis and Thrombosis Unit, I.R.C.C.S. Casa Sollievo della Sofferenza, S. Giovanni Rotondo, Foggia

 

COLLABORAZIONI INTERNAZIONALI

Department of Rheumatology and Clinical Immunology/Allergology, University Hospital of Bern, Switzerland

Lupus Research Unit, The Rayne Institute, St Thomas’ Hospital, London, UK

Department of Rheumatology and Clinical Immunology/Allergology, University Hospital of Bern, Switzerland

2Lupus Research Unit, The Rayne Institute, St Thomas’ Hospital, London, UK

3Joan and Sanford Weill College of Medicine of Cornell University, Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, New York, USA

4Division of Rheumatic Diseases, Department of Medicine, University of Connecticut Health Center, Farmington, USA

5Department of Internal Medicine and Rheumatology, Niguarda Hospital, Milano, Italy

6Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel, and Tel Aviv University, Israel

7Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy

8Department of Obstetrics and Gynaecology, Imperial College School of Medicine, London, UK

9Cattedra di Medicina Interna, University of Milano, Italy

10Institute of Obstetrics and Gynecology, L Mangiagalli, University of Milano, Italy

11Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, The Netherlands

12Department of Obstetrics and Gynecology, The University of Utah Health Sciences Center, Salt Lake City, Utah, USA

13Neonatology and Neonatal Intensive Care Unit, Spedali Civili, Brescia, Italy

14Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, Birmingham, UK

15Department of Internal Medicine, Hospital de Cruces, University of The Basque Country, Bizkaia, Spain

16Department of Obstetrics and Gynecology, University of Pavia, Italy

17University of Texas, Health Science Center, Houston, USA

18Pediatrics, Fondazione Policlinico Mangiagalli, Milano, Italy

19Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary

20Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

21Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Catalonia, Spain

22Discipline of Rheumatology, Faculdades de Ciencias Medicas, Universidade do Estado do Rio de Janeiro, Brazil

23Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy

24Lupus Center, Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, USA

25Department of Medicine and Center for Autoimmune Diseases, Sheba Medical Center, Tel-Aviv University, Tel-Hashomer, Israel

26Obstetric and Gynecology Department, University and Hospital of Brescia, Italy

27Cattedra di Reumatologia, Università ‘La Sapienza’, Roma, Italy

28Rheumatology and Clinical Immunology, University and Hospital of Brescia, Italy

Department of Rheumatology and Clinical Immunology/Allergology, University Hospital of Bern, Switzerland

2Lupus Research Unit, The Rayne Institute, St Thomas’ Hospital, London, UK

3Joan and Sanford Weill College of Medicine of Cornell University, Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, New York, USA

4Division of Rheumatic Diseases, Department of Medicine, University of Connecticut Health Center, Farmington, USA

5Department of Internal Medicine and Rheumatology, Niguarda Hospital, Milano, Italy

6Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel, and Tel Aviv University, Israel

7Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy

8Department of Obstetrics and Gynaecology, Imperial College School of Medicine, London, UK

9Cattedra di Medicina Interna, University of Milano, Italy

10Institute of Obstetrics and Gynecology, L Mangiagalli, University of Milano, Italy

11Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, The Netherlands

12Department of Obstetrics and Gynecology, The University of Utah Health Sciences Center, Salt Lake City, Utah, USA

13Neonatology and Neonatal Intensive Care Unit, Spedali Civili, Brescia, Italy

14Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, Birmingham, UK

15Department of Internal Medicine, Hospital de Cruces, University of The Basque Country, Bizkaia, Spain

16Department of Obstetrics and Gynecology, University of Pavia, Italy

17University of Texas, Health Science Center, Houston, USA

18Pediatrics, Fondazione Policlinico Mangiagalli, Milano, Italy

19Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary

20Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

21Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Catalonia, Spain

22Discipline of Rheumatology, Faculdades de Ciencias Medicas, Universidade do Estado do Rio de Janeiro, Brazil

23Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy

24Lupus Center, Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, USA

25Department of Medicine and Center for Autoimmune Diseases, Sheba Medical Center, Tel-Aviv University, Tel-Hashomer, Israel

26Obstetric and Gynecology Department, University and Hospital of Brescia, Italy

27Cattedra di Reumatologia, Università ‘La Sapienza’, Roma, Italy

28Rheumatology and Clinical Immunology, University and Hospital of Brescia, Italy

oan and Sanford Weill College of Medicine of Cornell University, Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, New York, USA

4Division of Rheumatic Diseases, Department of Medicine, University of Connecticut Health Center, Farmington, USA

5Department of Internal Medicine and Rheumatology, Niguarda Hospital, Milano, Italy

6Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel, and Tel Aviv University, Israel

7Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy

8Department of Obstetrics and Gynaecology, Imperial College School of Medicine, London, UK

9Cattedra di Medicina Interna, University of Milano, Italy

10Institute of Obstetrics and Gynecology, L Mangiagalli, University of Milano, Italy

11Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, The Netherlands

12Department of Obstetrics and Gynecology, The University of Utah Health Sciences Center, Salt Lake City, Utah, USA

13Neonatology and Neonatal Intensive Care Unit, Spedali Civili, Brescia, Italy

14Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, Birmingham, UK

15Department of Internal Medicine, Hospital de Cruces, University of The Basque Country, Bizkaia, Spain

16Department of Obstetrics and Gynecology, University of Pavia, Italy

17University of Texas, Health Science Center, Houston, USA

18Pediatrics, Fondazione Policlinico Mangiagalli, Milano, Italy

19Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary

20Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

21Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Catalonia, Spain

22Discipline of Rheumatology, Faculdades de Ciencias Medicas, Universidade do Estado do Rio de Janeiro, Brazil

23Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy

24Lupus Center, Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, USA

25Department of Medicine and Center for Autoimmune Diseases, Sheba Medical Center, Tel-Aviv University, Tel-Hashomer, Israel

26Obstetric and Gynecology Department, University and Hospital of Brescia, Italy

27Cattedra di Reumatologia, Università ‘La Sapienza’, Roma, Italy

 

  1. Systemic Autoimmune Disease Unit, Department of Internal Medicine; Obstetrics and Gynaecology Department, High Risk Unit, Vall d’Hebron University Hospital, Universitat Autonoma, Barcelona Spain
  2. Systemic Autoimmune Diseases Service, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
  3. Department of Medicine, Universitat Autonoma, Barcelona, Spain
  4. Obstetrics and Gynaecology Department, High Risk Unit, University Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
  5. Systemic Autoimmune Diseases Service, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
  6. Department of Internal Medicine, Hospital de Cruces, University of The Basque Country, Bizkaia, Spain
  7. Systemic Autoimmune Disease Unit, Internal Medicine Department, Althaia Healthcare Network of Manresa, Manresa, Barcelona, Spain
  8. Department of Medicine, Faculty of Medicine, Universitat Autònoma, Barcelona, Spain
  9. Systemic Autoimmune Diseases Service, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain
  10. Obstetrics and Gynaecology Department, High Risk Unit, Clinical Research Unit, Internal Medicine Department, Rheumatology Unit, Althaia Healthcare University Network of Manresa, Manresa, Barcelona, Spain
  11. Internal Medicine Department, Hospital Universitario La Paz, Universidad Autònoma, Madrid, Spain
  12. Obstetrics and Gynaecology Department, High Risk Unit, University Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
  13. Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain
  14. Internal Medicine Department, Hospital Universitario La Paz, Universidad Autònoma, Madrid, Spain
  15. Université Paris 13, Service d’Epidémiologie et Biostatistiques, Hôpital Avicenne, AP-Hôpitaux de Paris, Bobigny, Paris, France
  16. Universitè Paris 13, Service de Gynecologie-Obstetrique, Service de Medecine Interne, Service de Neonatologie et Pediatrie, Service d’Hemotologia Biologique, Laboratoire d’Hématologie, Unité Hémostase et Thrombose, Bondy, France
  17. AP-HP, Cochin Hospital, Internal Medicine Department, Centre de Référence Maladies Auto-immunes et Systémiques Rares, Paris, France
  18. Centre de référence maladies auto-immunes et systémiques rares, Service de médecine interne Pôle médecine, Université René Descartes Paris V Hôpital Cochin, Paris
  19. Center for Epidemiology and Statistics, Sorbonne Paris Cité (CRESS), Paris, France
  20. Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
  21. Vascular and Coagulation Department, University Hospital Angers, Angers, France
  22. Service d’Hematologie et Oncologie Biologique, Laboratoire d’Immunologia, Centre Hospitalier et Universitè de Poitiers, Paris, France
  23. Paris, France; AP-HP, Unitè Fonctionelles d’Immunologia Autoimmunitè et Hypersensibilites, Université Paris 7, Hopital Bichat-Claude Bernard, Paris (France)
  24. Service de Epidemiologie et Biostatistiques, Hopital Laborisière, AP-Hopitaux de Paris, Universitè Paris 7, Paris (France)
  25. Paris, France; AP-HP, Service de Gynécologie Obstétrique, Université Paris 7, Hôpital Trousseau Paris, France
  26. AP-HP, Hôpital Saint-Antoine, Service de médecine interne and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Sorbonne Universités, UPMC Univ Paris, Paris, (France)
  27. Université Paris 7, AP-HP, Cochin Hospital, Internal Medicine Department, Paris, France
  28. , Service de Epidemiologie et Biostatistiques, Hopital Avicenne, Paris 13, AP-Hopitaux de Paris, Bobigny, Universitè, Paris (France)
  29. AP-HP, Hôpital Saint-Antoine, Service de médecine interne, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Sorbonne Universités, UPMC Universitè Paris 06, Paris, France
  30. Service de médecine interne, Université Lille 2, Hôpital Claude Huriez, Lille, France
  31. Laboratoire d’Hematologie, Unitè Hèmostase et Thrombose, AP-HP, Hopital Jean Verdier, Bondy (France)
  32. Université Paris 13,AP-HP, Service de Gynécologie-Obstétrique; Service de médecine interne, Service de néonatologie et pédiatrie; Service de médecine interne, Service d’hématologie biologique Hôpital Jean Verdier, Bondy , France
  33. Gynecologie-Obstetrique, Neonatologie, Service d’hemalologia Biologique, Medicine Interne, CHU Poitiers (France)
  34. Université Nantes, Nantes, France; Service de médecine interne, Hopital Nantes, Nantes, France
  35. Hôpital Hôtel Dieu, Service de médecine interne, Université de Nantes, Nantes, France
  36. Service d’hématologie biologique, CHU de Nantes, Nantes (France)
  37. Department of Obstetrics and Gynecology, Centro Hospitalar de Lisboa Central, NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal
  38. Department of Paedriatics, Department Clinical Sciences, Faculty of Medicine, University of Turku, Turku, Finland
  39. Department of Systemic Rheumatic Disease, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
  40. Internal Medicine, “Bezanijska Kosa,” University Medical Center, Belgrade, Serbia
  41. Institute of laboratory diagnostics, Clinical center of Vojvodna, University of Medical School of Novi Sad, Novi Sad, Serbia
  42. Department of Gynecology-obstetrics, Rheumatology, Pediatrics, University Children’s Hospital, University Medical Center, Ljubljana (Slovenia)
  43. Foundation for the Community Control of Hereditary Diseases, Budapest (Hungary)
  44. Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland
  45. Department of Rheumatology and Clinical Immunology/Allergology, University Hospital of Bern (Switzerland) Department of Obstetrics, Medical University Graz, Graz, Austria
  46. Haematology Unit, Hippokration Hospital of Thessaloniki, Greece
  47. Lupus Research Unit, The Rayne Institute, Division of Women’s Health, St Thomas Hospital, London, (UK)
  48. Department of Obstetrics and Gynecology, Imperial College School of Medicine, London (UK)
  49. Louise Coote Lupus Unit, Guy’s and St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, London (UK)
  50. School of Basic and Medical Biosciences, King’s College London, London, UK
  51. Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, Birmingham (UK)
  52. The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
  53. Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht (The Netherlands)
  54. Department of Pediatric Rheumatology and Immunology, University Children’s Hospital Muenster Muenster, Germany
  55. University Children’s Hospital, University of Würzburg, Würzburg, Germany “Chorioamnionitis and Proinflammatory S100A12” (Catholic University of the Sacred Heart Protocol Record 100093, ClinicalTrial. Gov Identifier. NCT02996279)
  56. Department of Medicine, Karolinska Institutet, Department of Clinical Neuroscience, Department of Biosciences and Nutrition, Centre for Innovative Medicine, Karolinska University Hospital, Stockholm, Sweden
  57. Department of Internal Medicine and Rheumatology, Helsinki University Central Hospital, Helsinki, Finland
  58. Health Department, Social Insurance Institution of Finland, Helsinki, Finland
  59. Folkhälsan Institutet of Genetics, and Molecular Neurology Research Program, University of Helsinki, Helsinki, Finland
  60. Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway
  61. Department of Clinical Science, University of Bergen, Bergen, Norway
  62. Joan and Sanford Weill College of Medicine of Cornell University, Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, New York, USA
  63. University of Texas, Health Science Center, Houston, USA
  64. Division of Rheumatic Disease, Department of Medicine, University of Connecticut Health Center, Farmington (USA)
  65. Department of Obstetrics and Gynecology, The University of Utah Health Sciences Center, Salt Lake City, Utah (USA)
  66. University of Texas, Health Science Center, Houston (USA)
  67. University of Minnesota, Minneapolis, MN (USA)
  68. Lupus Center, Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore (USA)
  69. Discipline of Rheumatology, Faculdades de Ciencias Medicas, Universidade do Estado do Rio de Janeiro (Brazil)
  70. Department of Rheumatology, Dubai Hospital, Dubai, United Arab Emirates
  71. Autoimmune, Thrombophilic Diseases and Pregnancy Division, Dr. Carlos G Durand Hospital, Buenos Aires, Argentina
  72. Discipline of Rheumatology, Faculdades de Ciencias Medicas, Universidade do Estado do Rio de Janeiro, Brazil
  73. Department of Obstetrics and Gynecology, Maternal-Fetal Medicine, Department of Medicine and Center for Autoimmune Diseases, Sheba Medical Center, Tel-Aviv University, Tel-Hashomer (Israel)


COLLABORAZIONI A PROGETTI DI RICERCA
– CU89.04126.ct04 (Consiglio di presidenza 30/11/89) “Predittività dell’ipertensione gestazionale e della gestosi” Italia/USA-Caruso/Halberg
– CU90.01439.ct04 (Consiglio di presidenza 5/7/90) “Predittività dell’ipertensione gestazionale e della gestosi” Italia/USA-Caruso/Halberg
– CU91.00232.ct04 (Consiglio di presidenza 5/7/90) “Predittività dell’ipertensione gestazionale e della gestosi” Italia/USA-Caruso/Halberg
– CN 91. 00110.41. “Validazione clinica della velocimetria Doppler nell’impiego di patologie fetali di tipo ipossico”
– CN 92. 00044.41. “Validazione clinica della velocimetria Doppler nell’impiego di patologie fetali di tipo ipossico”
– CN 93. 00614.41. “Validazione clinica della velocimetria Doppler nell’impiego di patologie fetali di tipo ipossico”
– CU 93. 04304 CT 04 (1993). “Studio dell’aborto abituale: valutazione epidemiologica delle cause, identificazione delle complicanze ostetriche in relazione alle diverse patologie, e messa a punto dei protocolli di trattamento
– CU. 93. 04405. CT 04 (1993). “Effetto dell’aspirina a basse dosi sulla pressione arteriosa, sul trombossano e sulle prostacicline nelle gravidanze normali e complicate da ipertensione”

– CU. 94.00537.PF41 (1994) “Studio di parametri circolatori, endocrini e paracrini implicati nello sviluppo e funzione placento-fetale”

– CU. 95.00784.PF41 (1995) “Studio di parametri circolatori, endocrini e paracrini implicati nello sviluppo e funzione placento-fetale”
– PRIN 9906263933_004 (1999). “Preeclampsia, iposviluppo fetale, sindrome da antifosfolipidi e rottura prematura delle membrane. Protocolli per ritardare la prematurita del parto”. Durata 24 mesi

– Linea D1. 7020735 (2004) “Studio delle relazioni tra fattori di rischio vascolare e complicanze ostetriche”. Durata 24 mesi

 RESPONSABILE DI PROGETTI DI RICERCA
– Linea D1. (2005). 7020733. “Registro delle gravidanze con APS e follow-up dei nati”. Durata 24 mesi
– Linea D1. (2011). 70200776 “Studio prospettico sul ruolo di fattori infettivi in gravidanze fisiologiche ed in gravidanze complicate da malattie autoimmune”. Durata 24 mesi

– Linea D1. (2014). 70201187 “Idrossiclorochina e Sindrome da Anticorpi Anti-Fosfolipidi in Gravidanza”. Durata 24 mesi

-Linea D1. (2017) R4124500532 “Sindrome da anticorpi anti-fosfolipidi (APS) con tripla positività per aPL: effetto dell’idrossiclorochina sull’outcome ostetrico.” Durata 24 mesi

Linea D1. (2018) R4124500532 “Sindrome da anticorpi anti-fosfolipidi (APS) con tripla positività per aPL: effetto dell’idrossiclorochina sull’outcome ostetrico.” Durata 24 mesi

 ATTIVITÀ DIDATTICA ED INCARICHI DI INSEGNAMENTO
– Insegnamento agli studenti del sesto anno del Corso di Laurea in Medicina e Chirurgia dell’UCSC dal 1983 al 2012 (in affiancamento) e dal 2013 a tutt’oggi
– Insegnamento alla Scuola di Ostetricia (1988-1989 e 1989-1990) e alla Laurea Triennale in Ostetricia dell’UCSC dal 2005 a tutt’oggi

– Insegnamento alla Scuola di Specializzazione in Ostetricia e Ginecologia dell’UCSC dal 2001 ad oggi
– Insegnamento alla Scuola di Specializzazione in Medicina Tropicale dell’UCSC negli anni: dal 2002 al 2017

– Insegnamento alla Scuola di Specializzazione in Reumatologia dell’UCSC: dal 2003 ad oggi
– Insegnamento alla Scuola di Specializzazione in Malattie Infettive dell’UCSC negli anni: dal 2011 al 2016

– Docente al Master di Allergologia e Immunologia Clinica, presso UCSC nel 2014/2015

– Docente al Master di Ostetricia presso UCSC nel 2015/2016, 2016/2017, 2017/2018

– Docente al Corso di perfezionamento in “L’approccio multidisciplinare alla maternità ed alla psicopatologia perinatale presso UCSC nel 2016/2017, 2017/2018, 2018/2019


 ATTIVITA’ SCIENTIFICA

Campi di interesse
L’attività scientifica di Sara De Carolis si è svolta nell’ambito della Medicina Materno-Fetale, presso l’Università Cattolica del S. Cuore, (Roma) occupandosi di diversi argomenti di ricerca clinica e di base.

Patologia autoimmune in gravidanza (Sindrome da anticorpi antifosfolipidi, LES, Sindrome di Sjogren, Blocco cardiaco congenito, Lupus cutaneo neonatale, Morbo di Still)
Trombofilie congenite e deficit coagulativi in gravidanza
Complesso TORCH e ruolo delle false positività, malattie infettive in gravidanza

Patologia ipertensiva in gravidanza: Ipertensione cronica, Ipertensione gestazionale e preeclampsia

Ritardo di crescita fetale

Insulino-resistenza in gravidanzae e Trattamento del diabete in gravidanza
Nutrizione parenterale totale in gravidanza
Tumori associati alla gravidanza
Validazione clinica della metodica velocimetria Doppler materno-fetale

Piastrinopenia autoimmune in gravidanza
Studio epidemiologico e clinico dell’aborto ricorrente
Farmacocinetica e farmacoterapia in gravidanza
Parto pretermine, “Late preterm”, trombosi neonatali
Gravidanze plurime
Nefropatie e gravidanza
Cardiopatie e gravidanza
Morbo celiaco e malattie infiammatorie intestinali in gravidanza

Cronobiologia della pressione arteriosa in gravidanza

 

DIREZIONE O PARTECIPAZIONE A COMITATI EDITORIALI DI RIVISTE

 

  • Allergologia ed Immunopatologia
  • Annals of Reproductive Medicine and Treatment
  • Archives of Gynecology and Obstetrics
  • Archivum Immunologiae et Therapiae Experimentalis
  • Autoimmunity
  • Case Reports in Obstetrics and Gynecology
  • Clinical and experimental Immunology
  • Current Immunology Reviews
  • Expert Review of Hematology
  • European Journal of Internal medicine
  • European Journal of Obstetrics & Gynecology and Reproductive Biology
  • European Journal of Medical Rheumatology
  • International Journal of Clinical Rheumatology
  • International Journal of Autoimmune disorders & Therapy
  • Journal of Autoimmunity
  • Journal of Reproductive Immunology
  • Journal of Cardiology & Clinical Research
  • Journal of Heart and Circulation
  • Journal of Pediatric Intensive Care
  • JSM Atherosclerosis
  • Lupus
  • Mediterranean Journal of Hematology and Infectious Diseases
  • Nigerian Journal of Clinical Practice
  • Obstetrics and Gynecology International
  • Open Access Rheumatology: Research and Reviews
  • Open Autoimmunity Journal
  • Scandinavian Journal of Obstetrics and Gynecologist
  • Seminars in Arthritis and Rheumatism
  • SL Nutrition and food Science Journal
  • Thrombosis & Haemostasis
  • Thrombosis & Haemostasis: Research
  • The Journal of Obstetrics and Gynaecology Research

DIREZIONE O PARTECIPAZIONE A COMITATI EDITORIALI DI COLLANE EDITORIALI, ENCICLOPEDIE E TRATTATI DI RICONOSCIUTO PRESTIGIO

Collane editoriali

Trattato REUMATOLOGIA Edizioni SEU 1993

GESTOSI ’98 CIC EDIZIONI INTERNAZIONALI 01/1998 01/1998

Trattati MEDICINA MATERNO-FETALE Società Editrice Universo 01/1994 05/1994

Trattati GINECOLOGIA E OSTETRICIA NELLA PRATICA CLINICA “BENCHMARKING PERCORSI ASSISTENZIALI IN OSTETRICIA E GINECOLOGIA” Poletto Editore03/2004 06/2005

 

PUBBLICAZIONI

Articoli su rivista internazionale

 

  1. The European registry on obstetric Antiphospholipid syndrome (EUROAPS): A survey of 1000 consecutive cases. Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Marozio L, Espinosa G, Cervera R, Ríos-Garcés R, De Carolis S, Latino O, LLurba E, Chighizola CB, Gerosa M, Pengo V, Lundelin K, Rovere-Querini P, Canti V, Mayer-Pickel K, Reshetnyak T, Hoxha A, Tabacco S, Stojanovich L, Gogou V, Varoudis A, Arnau A, Ruiz-Hidalgo D, Trapé J, Sos L, Stoppani C, Martí-Cañamares A, Farran-Codina I; EUROAPS Study Group. Autoimmun Rev. 2019 Feb 15. pii: S1568-9972(19)30038-2.
  2. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome. De Carolis S, Tabacco S, Rizzo F, Giannini A, Botta A, Salvi S, Garufi C, Benedetti Panici P, Lanzone A. Autoimmun Rev. 2018 Oct;17(10):956-966.
  3. A Monocentric cohort of Obstetric seronegative anti-Phospholipid syndrome. Truglia S, Capozzi A, Mancuso S, Recalchi S, Spinelli FR, Perricone C, De Carolis C, Manganelli V, Riitano G, Garofalo T, Longo A, De Caroli Ss, Alessandri C, Misasi R, Valesini G, SoriceM, Conti F. Front Immunol. 2018; 9: 1678.
  4. Influence of Biliopancreatic Diversion on Pregnancy Outcomes in Comparison to Other Bariatric Surgery Procedures. S. De Carolis, A. Botta, Gelsomina Del Sordo, R. Guerrisi, S. Salvi, M. P. De Carolis, A. Iaconelli, P. Giustacchini, M. Raffaelli, A. Lanzone. Obesity Surgery [16 Jun 2018] Type: Journal Article DOI: 10.1007/s11695-018-3350-5
  5. Gestational weight gain as an independent risk factor for adverse pregnancy outcomes in women with gestational diabetes. F. Macrì, D. Pitocco, E. di Pasquo, S. Salvi, A. Rizzi, M. Di Leo, L. Tartaglione, E. Di Stasio, A. Lanzone, S. De Carolis. Eur Rev Med Pharmacol Sci 2018; 22 (14): 4403-4410 DOI: 10.26355/eurrev_201807_15490
  6. The effect of additional treatments combined with conventional therapies in high risk antiphospholipid syndrome pregnant patients: A multicentre study. Ruffatti A, Tonello M, Ariela Hoxha A, Sciascia S, Cuadrado MJ, Latino JO, Udry S, Reshetnyak T, Costedoat-Chalumeau, NM, Marozio L, Tincani A, Andreoli L, Haladyj E, Meroni PL, Gerosa M, Alijotas-Reig J, Tenti S, Mayer-Pickel K, Simchen MJ, Bertero MT, De Carolis S, Ramoni V, Mekinian A, Grandone E, Maina A, Serrano F, Pengo V, Munther A. Khamashta. Thromb Haemost. 2018 Apr;118(4):639-646.
  7. European families reveal MHC class I and II associations with autoimmune-mediated congenital heart block. Kyriakidis NC, Kockum I, Julkunen H, Hoxha A, Salomonsson S, Meneghel L, Ebbing C; Swedish Congenital Heart Block Study Group, Dilthey A, Eronen M, De Carolis S, Kiserud T, Ruffatti A, Kere J, Meisgen S, Wahren-Herlenius. Ann Rheum Dis. 2018 Sep;77(9):1381-1382.
  8. Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies. Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, LLurba E, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Espinosa G, de Carolis S, Rovere-Querini P, Lundelin K, Picardo E, Mekinian A; EUROAPS Study Group. Med Clin (Barc). 2018 Sep 21;151(6):215-222.
  9. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women. De Carolis S, Tabacco S, Rizzo F, Perrone G, Garufi C, Botta A, Salvi S, Benedetti Panici P, Lanzone A. Lupus. 2018 Apr;27(5):841-846.
  10. Hydroxychloroquine as additional treatment in pregnant patients with refractory APS. De Carolis S, Rizzo F, Tabacco S. Am J Obstet Gynecol. 2017 Dec;217(6):711-712.
  11. Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study. Mekinian A, Alijotas-Reig J, Carrat F, Costedoat-Chalumeau N, Ruffatti A, Lazzaroni MG, Tabacco S, Maina A, Masseau A, Morel N, Esteve-Valverde EE, Ferrer-Oliveras R, Andreoli L, De Carolis S, Josselin-Mahr L, Abisror N, Nicaise-Roland P, Tincani A, Fain O; on the behalf of the SNFMI and the European Forum on Antiphospholipid Antibodies. Autoimmun Rev. 2017 Jul;16(7):730-734
  12. Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature.

Zuppa AA, Riccardi R, Frezza S, Gallini F, Luciano RM, Alighieri G, Romagnoli C, De Carolis S. Autoimmun Rev. 2017 Apr;16(4):427-432.

  1. The transition from intra to extra-uterine life in late preterm infant: a single-center study. De Carolis MP, Pinna G, Cocca C, Rubortone SA, Romagnoli C, Bersani I, Salvi S, Lanzone A, De Carolis S. Ital J Pediatr. 2016 Sep 22 ;42(1):87.
  2. Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy? Garofalo S, Degennaro VA, Salvi S, De Carolis MP, Capelli G, Ferrazzani S, De Carolis S, Lanzone A. Eur J Cancer Care. 2017 Nov;26(6).
  3. Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort. Alijotas-Reig J, Ferrer-Oliveras R, Esteve-Valverde E, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Espinosa G, Coloma E, De Carolis S, Rovere-Querini P, Canti V, Picardo E, Fredi M, Mekinian A; EUROAPS Study Group. Am J Reprod Immunol. 2016 Aug 76; (2):164-71.
  4. Fetal hypoxia secondary to severe maternal anemia as a causative link between blueberry muffin baby and erythroblastosis: a case report. De Carolis MP, Salvi S, Bersani I, Lacerenza S, Romagnoli C, De Carolis S. J Med Case Rep. 2016 Jun 13; 10(1):155.
  5. Predictors of Pregnancy Outcome in Antiphospholipid Syndrome: A Review Tabacco S, Salvi S, De Carolis S, *, Botta A, Ferrazzani S, Garufi C, Benedetti Panici P, Lanzone A, De Carolis MP. J Allergy Ther 2016, 7:3
  6. Development of a new foetal growth curve from a large sample of italian population. Ferrazzani S, Degennaro VA, Di Stasio E, Poppa G, Moresi S, Salvi S, Lanzone A, De Carolis S. Minerva Pediatr. 2017 Aug;69(4):245-250. doi: 10.23736/S0026-4946.16.04258-4. Epub 2015 Sep 10.
  7. A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy. Buonomo A, Nucera E, De Carolis S, De Stefano V, Pascolini L, Di Pasquo E, Betti S, Schiavino D. J Investig Allergol Clin Immunol. 2015; 25(3):229-31
  8. Is gestational hypertension beneficial in twin pregnancies? Ferrazzani S, Moresi S, De Feo E, Degennaro VA, Salvi S, Boccia S, Lanzone A, De Carolis S. Pregnancy Hypertens. 2015 Apr;5(2):171-6.
  9. Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment? De Carolis S, Botta A, Salvi S, di Pasquo E, Del Sordo G, Garufi C, Lanzone A, De Carolis MP. Autoimmun Rev. 2015 Sep;14 (9):760-2
  10. Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. De Carolis S, di Pasquo E, Rossi E, Del Sordo G, Buonomo A, Schiavino D, Lanzone A, De Stefano V. Thromb Res. 2015 Jun;135 (6):1049-51
  11. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases. Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Coloma-Bazan E, De Carolis S, Espinosa G, Rovere-Querini P, Kuzenko A, Valverde EE, Robles A, Cervera R, Canti V, Fredi M, Gil-Aguado A, Lundelin K, Llurba E, Melnychuk T, Nalli C, Picardo E, Silvestro E, del Ross T, Farran-Codina I; (EUROAPS Study Group Collaborators). Autoimmun Rev. 2015 May;14 (5):387-95
  12. Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? De Carolis MP, Salvi S, Botta A, Cocca C, Garufi C, Lanzone A, De Carolis S. Lupus. 2015 Mar;24 (3):231-4
  13. Interleukin-22: biomarker of maternal and fetal inflammation? Bersani I, De Carolis MP, Foell D, Weinhage T, Rossi ED, De Carolis S, Rubortone SA, Romagnoli C, Speer CP. Immunol Res. 2015 Feb;61 (1-2):4-10
  14. Placental and infant metastasis of maternal melanoma: a new case. De Carolis S, Garofalo S, Degennaro VA, Zannoni GF, Salvi S, Moresi S, Di Pasquo E, Scambia G. J Obstet Gynaecol. 2015 May;35 (4):417-8
  15. Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome? Mekinian A, Costedoat-Chalumeau N, Masseau A, Tincani A, De Carolis S, Alijotas-Reig J, Ruffatti A, Ambrozic A, Botta A, Le Guern V, Fritsch-Stork R, Nicaise-Roland P, Carbonne B, Carbillon L, Fain O. Autoimmun Rev. 2015 Jan;14(1):23-9. Review
  16. Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study. Mekinian A, Costedoat-Chalumeau N, Masseau A, Botta A, Chudzinski A, Theulin A, Emmanuelli V, Hachulla E, De Carolis S, Revaux A, Nicaise P, Cornelis F, Subtil D, Montestruc F, Bucourt M, Chollet-Martin S, Carbillon L, Fain O; SNFMI and the European Forum of APS. Autoimmunity. 2015 Feb;48 (1):40-5
  17. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Ruffatti A, Salvan E, Del Ross T, Gerosa M, Andreoli L, Maina A, Alijotas-Reig J, De Carolis S, Mekinian A, Bertero MT, Canti V, Brucato A, Bremme K, Ramoni V, Mosca M, Di Poi E, Caramaschi P, Galeazzi M, Tincani A, Trespidi L. Thromb Haemost. 2014 Oct;112 (4):727-35
  18. Look at the lung: can chest ultrasonography be useful in pregnancy? Inchingolo R, Smargiassi A, Mormile F, Marra R, De Carolis S, Lanzone A, Valente S, Corbo GM. Multidiscip Respir Med. 2014 Jun 6 (1):32
  19. Use of an intrauterine inflated catheter balloon in massive post-partum hemorrhage: a series of 52 cases. Ferrazzani S, Iadarola R, Perrelli A, Botta A, Moresi S, Salvi S, Santucci S, Degennaro VA, De Carolis S. J Obstet Gynaecol Res. 2014 Jun;40 (6):1603-10
  20. Cord entanglement. Salvi S, De Carolis S, Garofalo S, Del Sordo G, Garufi C, De Carolis MP. Arch Dis Child Fetal Neonatal Ed. 2014 Nov;99(6):F457.
  21. The impact of primary Sjogren’s syndrome on pregnancy outcome: our series and review of the literature. De Carolis S, Salvi S, Botta A, Garofalo S, Garufi C, Ferrazzani S, De Carolis MP. Autoimmun Rev. 2014 Feb;13 (2):103-7.
  22. Can We Prevent Preeclampsia? Pharmacologic Prevention of Preeclampsia. De Carolis, S., Di Pasquo, E., Ferrazzani, S., Garofalo, S., Martino, C., Botta, A., Salvi, S., Moresi, S., Del Sordo, G., Lanzone, A. Controversies in Preeclampsia. January 01, 2014:211-22.
  23. European registry of babies born to mothers with antiphospholipid syndrome. Mekinian A, Lachassinne E, Nicaise-Roland P, Carbillon L, Motta M, Vicaut E, Boinot C, Avcin T, Letoumelin P, De Carolis S, Rovere-Querini P, Lambert M, Derenne S, Pourrat O, Stirnemann J, Chollet-Martin S, Biasini-Rebaioli C, Rovelli R, Lojacono A, Ambrozic A, Botta A, Benbara A, Pierre F, Allegri F, Nuzzo M, Hatron PY, Tincani A, Fain O, Aurousseau MH, Boffa MC. Ann Rheum Dis. 2013 Feb;72 (2):217-22.
  24. Role of Complement in pregnancy with Antiphospholipid Syndrome: Mechanisms of Pathogenesis And Clinical Aspects. De Carolis S, Vitucci A, Garofalo S, Salvi S, Del Sordo G, Rella R, Botta A. Int J Clin Rheumatol. June 2013;8, 3; 399-405.
  25. An interlabial mass. De Carolis MP, Rubortone SA, Romano V, De Carolis D, De Carolis S. Arch Dis Child Fetal Neonatal Ed. 2012 Sep;97 (5):F376
  26. Complementemia and obstetric outcome in Antiphospholipid syndrome pregnancies. De Carolis, A. Botta, S. Salvi, G. Del Sordo, M.P. De Carolis. Rheumatology (Oxford) 2012: 51(12)
  27. Isolated cerebral sinovenous thrombosis: a rare case of neonatal antiphospholipid syndrome. De Carolis MP, Salvi S, Bersani I, De Carolis S. Indian Pediatr. 2012 May;49 (5):411-2.
  28. The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome. De Carolis S, Santucci S, Botta A, Salvi S, Degennaro VA, Garufi C, Garofalo S, Ferrazzani S, Scambia G. Lupus. 2012 Jun;21 (7):773-5
  29. Follow-up of babies born to mothers with antiphospholipid syndrome: preliminary data from the European neonatal registry. Motta M, Boffa MC, Tincani A, Avcin T, De Carolis S, Lachassinne E. Lupus. 2012 Jun;21 (7):761-3
  30. European registry of babies born to mothers with antiphospholipid syndrome. Mekinian A, Lachassinne E, Nicaise-Roland P, Carbillon L, Motta M, Vicaut E, Boinot C, Avcin T, Letoumelin P, De Carolis S, Rovere-Querini P, Lambert M, Derenne S, Pourrat O, Stirnemann J, Chollet-Martin S, Biasini-Rebaioli C, Rovelli R, Lojacono A, Ambrozic A, Botta A, Benbara A, Pierre F, Allegri F, Nuzzo M, Hatron PY, Tincani A, Fain O, Aurousseau MH, Boffa MC. Ann Rheum Dis. 2013 Feb;72(2):217-22.
  31. Positive outcome in a patient with Wilson’s disease treated with reduced zinc dosage in pregnancy. Masciullo M, Modoni A, Bianchi ML, De Carolis S, Silvestri G. Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159 (1):237-8
  32. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero MT, Pengo V, Boffa MC, Tincani A. Rheumatology (Oxford). 2011 Sep;50 (9):1684-9
  33. Neonatal outcome in hypertensive disorders of pregnancy. Ferrazzani S, Luciano R, Garofalo S, D’Andrea V, De Carolis S, De Carolis MP, Paolucci V, Romagnoli C, Caruso A. Early Hum Dev. 2011 Jun;87 (6):445-9.
  34. Maternal-neonatal vitamin K deficiency secondary to maternal biliopancreatic diversion. Bersani I, De Carolis MP, Salvi S, Zecca E, Romagnoli C, De Carolis S. Blood Coagul Fibrinolysis. 2011 Jun;22 (4):334-6
  35. European registry of infants born to mothers with antiphospholipid syndrome: preliminary results. Motta M, Lachassinne E, Boffa MC, Tincani A, Avcin T, De Carolis S, Aurousseau MH, Le Toumelin P, Lojacono A, De Carolis MP, Chirico G. Minerva Pediatr. 2010 Jun;62 (3 Suppl 1):25-7
  36. Peripheral blockade as treatment of arm ischaemia at birth. De Carolis MP, Bersani I, Frassanito L, Fusco FP, De Carolis S, Romagnoli C. Eur J Pediatr. 2010 Oct;169(10):1267-9.
  37. False-positive IgM for CMV in pregnant women with autoimmune disease: a novel prognostic factor for poor pregnancy outcome. De Carolis S, Santucci S, Botta A, Garofalo S, Martino C, Perrelli A, Salvi S, Degennaro V, de Belvis A, Ferrazzani S, Scambia G. Lupus. 2010 Jun;19(7):844-9.
  38. Predictors of pregnancy outcome in antiphospholipid syndrome: a review. De Carolis S, Botta A, Santucci S, Garofalo S, Martino C, Perrelli A, Salvi S, Ferrazzani S, Caforio L, Scambia G. Clin Rev Allergy Immunol. 2010 Apr;38(2-3):116-24
  39. Which intrauterine treatment for autoimmune congenital hearth block? De Carolis, S. Salvi, A. Botta, S. Santucci, C. Martino, S. Garofalo and S. Ferrazzani. The Open Autoimmunity Journal. 2010; 2,1-10. DOI: 10.2174/1876894601002010001
  40. European registry of babies born to mothers with antiphospholipid syndrome: a result update. Boffa MC, Lachassinne E, Boinot C, De Carolis S, Rovere-Querini P, Avcin T, Biasini-Rebaioli C, Le Toumelin P, Aurousseau MH, Tincani A. Lupus. 2009 Sep;18(10):900-4
  41. Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort. Boffa MC, Boinot C, De Carolis S, Rovere-Querini P, Aurousseau MH, Allegri F, Nicaise-Roland P, Barra A, Botta A, Ambrozic A, Avcin T, Tincani A. Thromb Haemost. 2009 Jul;102(1):25-8
  42. Atypical manifestations of congenital parvovirus B19 infection. Savarese I, De Carolis MP, Costa S, De Rosa G, De Carolis S, Lacerenza S, Romagnoli C. Eur J Pediatr. 2008 Dec;167(12):1463-6
  43. Uterine artery velocity waveforms as predictors of pregnancy outcome in patients with antiphospholipid syndrome: a review. De Carolis S, Botta A, Garofalo S, Ferrazzani S, Martino C, Fatigante G, Caforio L, Caruso A. Ann N Y Acad Sci. 2007 Jun;1108:530-9
  44. Mild and transient neutropenia in an infant of mother with Wegener’s granulomatosis. Zuppa AA, De Luca D, Cota F, De Carolis S, Savone R, Manna R. Minerva Pediatr. 2006 Dec;58(6):579-81.
  45. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Sergio Ferrazzani, Maria Clara D, Gabriella Fatigante, Giorgia Sorega, Sara De Carolis, Giancarlo Paradisi, Alessandro Caruso. Hypertens Pregnancy. 2006;25(2):115-27.
  46. Cancer in pregnancy: results of a series of 32 patients. De Carolis S, Grimolizzi F, Garofalo S, Fatigante G, Ferrazzani S, Carducci B, Caruso A. Anticancer Res. 2006 May-Jun;26(3B):2413-8.
  47. Anti-inflammatory and immunosuppressive drugs and reproduction. Østensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai R, Meroni P, Cetin I, Derksen R, Branch W, Motta M, Gordon C, Ruiz-Irastorza G, Spinillo A, Friedman D, Cimaz R, Czeizel A, Piette JC, Cervera R, Levy RA, Clementi M, De Carolis S, Petri M, Shoenfeld Y, Faden D, Valesini G, Tincani A. Arthritis Res Ther. 2006;8(3):209.
  48. Inherited thrombophilia: treatment during pregnancy. De Carolis S, Ferrazzani S, De Stefano V, Garofalo S, Fatigante G, Rossi E, Leone G, Caruso A. Fetal Diagn Ther. 2006;21(3):281-6.
  49. Celiac disease and inflammatory bowel disease in pregnancy. De Carolis S, Botta A, Fatigante G, Garofalo S, Ferrazzani S, Gasbarrini A, Caruso A. Lupus. 2004;13(9):653-8
  50. Maternal mortality in Italy, 1980-1996. Biaggi A, Paradisi G, Ferrazzani S, De Carolis S, Lucchese A, Caruso A. Eur J Obstet Gynecol Reprod Biol. 2004 Jun 15;114(2):144-9
  51. Prostaglandin: cervical ripening in hypertensive pregnancies. Ferrazzani S, De Santis L, Carducci B, Caliandro D, De Carolis S, Di Simone N, Caruso A. Acta Obstet Gynecol Scand. 2003 Jun;82(6):510-5.
  52. Pregnancy during chronic hemodialysis: a single dialysis-unit experience with five cases. Luciani G, Bossola M, Tazza L, Panocchia N, Liberatori M, De Carolis S, Piccioni E, De Carolis MP, Caruso A, Castagneto M. Ren Fail. 2002 Nov;24(6):853-62.
  53. Abnormal carbohydrate metabolism during pregnancy : association with endothelial dysfunction. Paradisi G, Biaggi A, Ferrazzani S, De Carolis S, Caruso A. Diabetes Care. 2002 Mar;25(3):560-4.
  54. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation. Breccia M, Cimino G, Alimena G, De Carolis S, Lo Coco F, Mandelli F. Haematologica. 2002 Feb;87(2):ELT12.
  55. Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. De Santis M, Lucchese A, De Carolis S, Ferrazani S, Caruso A. Eur J Cancer Care (Engl). 2000 Dec;9(4):235-7.
  56. There is poor agreement between manual auscultatory and automated oscillometric methods for the measurement of blood pressure in normotensive pregnant women. Pomini F, Scavo M, Ferrazzani S, De Carolis S, Caruso A, Mancuso S. J Matern Fetal Med. 2001 Dec;10(6):398-403.
  57. Uterine myomectomy in pregnant women. De Carolis S, Fatigante G, Ferrazzani S, Trivellini C, De Santis L, Mancuso S, Caruso A. Obstetrical & Gynecological Survey, 450-451, 2001
  58. Uterine myomectomy in pregnant women. De Carolis S, Fatigante G, Ferrazzani S, Trivellini C, De Santis L, Mancuso S, Caruso A. Fetal Diagn Ther. 2001 Mar-Apr;16(2):116-9.
  59. Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease. Gasbarrini A, Torre ES, Trivellini C, De Carolis S, Caruso A, Gasbarrini G. Lancet. 2000 Jul 29;356(9227):399-400.
  60. Emergency cerclage in the presence of protruding membranes: is pregnancy outcome predictable? Caruso A, Trivellini C, De Carolis S, Paradisi G, Mancuso S, Ferrazzani S. Acta Obstet Gynecol Scand. 2000 Apr;79(4):265-8.
  61. Emergency cerclage in the presence of protruding membranes: is pregnancy outcome predictable? Caruso A, Trivellini C, De Carolis S, Paradisi G, Mancuso S, Ferrazzani S. Obstetrical & Gynecological Survey 672-673, 2000
  62. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Di Simone N, Meroni PL, de Papa N, Raschi E, Caliandro D, De Carolis S, Khamashta MA, Atsumi T, Hughes GR, Balestrieri G, Tincani A, Casali P, Caruso A. Arthritis Rheum. 2000 Jan;43(1):140-50
  63. Birth weight in pre-eclamptic and normotensive twin pregnancies: an analysis of discordance and growth restriction. Ferrazzani S, Merola A, De Carolis S, Carducci B, Paradisi G, Caruso A. Hum Reprod. 2000 Jan;15(1):210-7.
  64. Carbohydrate metabolism in gestational diabetes: effect of chronic hypertension. Caruso A, Ferrazzani S, De Carolis S, Lucchese A, Lanzone A, Paradisi G. Obstet Gynecol. 1999 Oct;94(4):556-61.
  65. Antiphospholipid antibodies in obstetrics: new complexities and sites of action. Caruso A, De Carolis S, Di Simone N. Hum Reprod Update. 1999 May-Jun;5(3):267-76.
  66. Gestational hypertension but not pre-eclampsia is associated with insulin resistance syndrome characteristics. Caruso A, Ferrazzani S, De Carolis S, Lucchese A, Lanzone A, De Santis L, Paradisi G. Hum Reprod. 1999 Jan;14(1):219-23.
  67. Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Di Simone N, Caliandro D, Castellani R, Ferrazzani S, De Carolis S, Caruso A. Hum Reprod. 1999 Feb;14(2):489-95.
  68. Pregnancy outcome and total parenteral nutrition in malnourished pregnant women. Caruso A, De Carolis S, Ferrazzani S, Trivellini C, Mastromarino C, Pittiruti M. Obstetrical & Gynecological Survey, 85-87, 1999
  69. Pregnancy outcome and total parenteral nutrition in malnourished pregnant women. Caruso A, De Carolis S, Ferrazzani S, Trivellini C, Mastromarino C, Pittiruti M. Fetal Diagn Ther. 1998 May-Jun;13(3):136-40.
  70. Therapeutic amnioinfusions and fetal fibronectin pattern in a case with preterm ruptured membranes that resealed. De Carolis S, Carducci B, De Santis L, Ferrazzani S, Noia G, Merola A, Caruso A. Fetal Diagn Ther. 1998 Mar-Apr;13(2):66-8.
  71. Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera. Di Simone N, Ferrazzani S, Castellani R, De Carolis S, Mancuso S, Caruso A. Hum Reprod. 1997 Sep;12(9):2061-5.
  72. Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature. Noia G, De Carolis S, De Stefano V, Ferrazzani S, De Santis L, Carducci B, De Santis M, Caruso A. Acta Obstet Gynecol Scand. 1997 Oct;76(9):890-2.
  73. The use of prostaglandin E2 for cervical ripening in patients requiring induction of labour. Caruso A, De Santis L, Carducci B, Ferrazzani S, De Carolis S, Mancuso S. J Int Med Res. 1997 May-Jun;25(3):159-66.
  74. Term and postterm low-risk pregnancies: management schemes for the reduction of high rates of cesarean section. Mancuso S, Ferrazzani S, De Carolis S, Carducci B, De Santis L, Caruso A. Minerva Ginecol. 1996 Mar;48(3):95-8.
  75. Polycystic ovary disease. A risk factor for gestational diabetes? Lanzone A, Caruso A, Di Simone N, De Carolis S, Fulghesu AM, Mancuso S. J Reprod Med. 1995 Apr;40(4):312-6.
  76. In vitro effect of antiphospholipid antibody-containing sera on basal and gonadotrophin releasing hormone-dependent human chorionic gonadotrophin release by cultured trophoblast cells. Di Simone N, De Carolis S, Lanzone A, Ronsisvalle E, Giannice R, Caruso A. Placenta. 1995 Jan;16(1):75-83.
  77. Poor pregnancy outcome and anticardiolipin antibodies. De Carolis S, Caruso A, Ferrazzani S, Carducci B, De Santis L, Mancuso S. Fetal Diagn Ther. 1994 Sep-Oct;9(5):296-9.
  78. The duration of hypertension in the puerperium of preeclamptic women: relationship with renal impairment and week of delivery. Ferrazzani S, De Carolis S, Pomini F, Testa AC, Mastromarino C, Caruso A. Am J Obstet Gynecol. 1994 Aug;171(2):506-12.
  79. The use of nifedipine as first-line hypotensive therapy in gestational hypertension. Caruso A, Ferrazzani S, De Carolis S, Romano D, Mancinelli S, De Carolis MP. Minerva Ginecol. 1994 May;46(5):279-84.
  80. Pregnancy outcome in women with cardiac valve prosthesis. Caruso A, De Carolis S, Ferrazzani S, Paradisi G, Pomini F, Pompei A. Eur J Obstet Gynecol Reprod Biol. 1994 Mar 31;54(1):7-11.
  81. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Caruso A, De Carolis S, Ferrazzani S, Valesini G, Caforio L, Mancuso S. Obstet Gynecol. 1993 Dec;82(6):970-7.
  82. Immune thrombocytopenic purpura and percutaneous umbilical blood sampling: an open question. De Carolis S, Noia G, De Santis M, Trivellini C, Mastromarino C, De Carolis MP, Ferrazzani S, Caruso A. Fetal Diagn Ther. 1993 May-Jun;8(3):154-60.
  83. Continuous subcutaneous administration of terbutaline in the therapy of threatening premature labour. Pomini F, De Carolis S, Ferrazzani S, De Santis L, Carducci B, Caruso A. Minerva Ginecol. 1993 Jan-Feb;45(1-2):57-63.
  84. Placental transfer of phenobarbital: what is new? De Carolis MP, Romagnoli C, Frezza S, D’Urzo E, Muzii U, Mezza A, Ferrazzani S, De Carolis S. Dev Pharmacol Ther. 1992;19(1):19-26.
  85. Low-dose aspirin and vascular response in pregnant patients sensitive to angiotensin II. Caruso A, Ferrazzani S, De Carolis S, Lanzone A, Mancuso S. Int J Gynaecol Obstet. 1991 Jun;35(2):123-8.
  86. Proteinuria and outcome of 444 pregnancies complicated by hypertension. Ferrazzani S, Caruso A, De Carolis S, Martino IV, Mancuso S. Am J Obstet Gynecol. 1990 Feb;162(2):366-71.
  87. Chronobiologic approach to pregnancy-induced hypertension and individualized assessment of low-dose aspirin for pre-eclampsia prevention. Ferrazzani S, Cornélissen G, Caruso A, De Carolis S, Hillman D, Di Giglio R, Vercillo Martino I, Pometti A, Tocci A, Kato J, et al. Prog Clin Biol Res. 1990;341A:395-402.
  88. Aldosterone, kallikrein, kininase I and II in normal and hypertension complicated pregnancy. Ferrazzani S, Leardi P, Magnotti DL, De Carolis S, Moneta E, Porcelli G, Volpe AR, Menini E, Liberale I. Adv Exp Med Biol. 1989;247B:455-61.
  89. Placental-derived PGI2 inhibits cord blood platelet function. Landolfi R, De Cristofaro R, Ciabattoni G, De Carolis S, Durazzi S, Mancini S, Bizzi B. 1988 May-Jun;73(3):207-10
  90. Management of pregnancy in women with antithrombin III congenital defect: report of four cases. De Stefano V, Leone G, De Carolis S, Ferrelli R, Di Donfrancesco A, Moneta E, Bizzi B. Thromb Haemost. 1988 Apr 8;59(2):193-6.
  91. Antenatal phenobarbital in preventing intraventricular hemorrhage in premature newborns. De Carolis S, De Carolis MP, Caruso A, Oliva GC, Romagnoli C, Ferrazzani S, Muzii U, Luciano R, Mancuso S. Fetal Ther. 1988;3(4):224-9.
  92. Serum protein distribution in hydatidiform mole. An immunohistochemical study. Massi G, Coli A, De Carolis S. Arch Pathol Lab Med. 1987 Aug;111(8):723-5.
  93. Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect. De Stefano V, Leone G, De Carolis MP, Ferrelli R, De Carolis S, Pagano L, Tortorolo G, Bizzi B. Thromb Haemost. 1987 Jun 3;57(3):329-31.
  94. Neonatal diagnosis of antithrombin III congenital defect in a premature newborn. De Stefano V, Di Donfrancesco A, De Carolis S, De Carolis MP, Moneta E, Leone G. Br J Haematol. 1987 Jan;65(1):117-9.

LETTERS

  1. Haemoglobin discordances in twins: is “really” due to differences in timing of cord clamping? A consideration to Verbeek L and co-authors. De Carolis MP, Garufi C, De Carolis S. Arch Dis Child Fetal Neonatal Ed, January 2017; eLetter 23.
  2. Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome. De Carolis S, Botta A, Santucci S, Salvi S, Moresi S, Di Pasquo E, Del Sordo G, Martino C. Lupus. 2012 Jun;21 (7):776-8
  3. How to use lupus anticoagulant in neonates born to mothers with antiphospholipid syndrome. De Carolis MP, Bersani I, Salvi S, Garufi C, De Carolis S. Arch Dis Child, 302321, 2012

 

ABSTRAC

ABSTRACT SU RIVISTA

  1. HYDROXYCLOROQUINE IN PRIMARY APS PREGNANT WOMEN WITH TRIPLE POSITIVITY: EFFECTS ON APL LEVELS AND PREGNANCY OUTCOME C. Garufi1, S. Tabacco2, S. Salvi3, A. Botta4, E. Di Pasquo5, G. Del Sordo6, S. Moresi7, M.P. De Carolis8, A. Lanzone9, S. De Carolis10. Clin Exp Rheumatol 2016
  2. HYPOGLYCEMIA AND HYPERGLYCEMIA IN EXTREMELY LOW-BIRTH-WEIGHT INFANTS. De Carolis MP, Rubortone SA, , Cocca C, Pinna E., Tiberi E, Zecca E, Romagnoli C, Salvi S, De Carolis S. Ital J Pediatr. 2015; 41(Suppl1): A7
  3. THE TRANSITION OF LATE PRETERM. Maria Pia De Carolis, Carmen Cocca, Serena Antonia Rubortone, Giovanni Pinna, Sara De Carolis, Silvia Salvi, and Costantino Romagnoli Ital J Pediatr. 2014; 40 (Suppl 2): A2. Published online 2014 Oct 9. doi: [10.1186/1824-7288-40-S2-A2]
  4. MOTHERS’ ANTIPHOSPHOLIPID ANTIBODIES DURING PREGNANCY AND THE RELATION TO OFFSPRING OUTCOME. Mekinian A, Carbillon L, Nicaise-Roland P, Rousseau H, Lachassinne E, Motta M, Vicaut E, Boinot C, Avcin T, De Carolis S, Rovere-Querini P, Lambert M, Derenne S, Pourrat O, Chollet-Martin S, Biasini-Rebaioli R, Rovelli R, Lojacono A, Ambrozic A, Benbara A, Pierre F, Allegri F, Nuzzo M, Hatron PY, Tincani A, Aurousseau MH, Boffa MC, Fain O. Clin Exp Rheumatol. 2014 May-Jun;32 (3):446
  5. HYPERTENSIVE DISORDERS OF PREGNANCY AND FETAL GROWTH IN TWIN PREGNANCIES: A REVIEW. Ferrazzani S, Moresi s, Garofalo S, Degennaro VA, Salvi S, Di Pasquo E, Del Sordo G, De Carolis S. TWIN RESEARCH AND HUMAN GENETICS, ISSN: 1832-4274. (2012)
  6. HYPERTENSIVE DISORDERS IN PREGNANT WOMEN AFFECTED BY TYPE I DIABETES. Ferrazzani S, Di Pasquo E, Moresi S, Martino C, Salvi S, Degennaro VA, Del Sordo G, De Carolis S. Pregnancy Hypertens. 2012 Jul;2 (3):324-5
  7. GESTATIONAL HYPERTENSION AND BIRTH WEIGHT IN TWIN PREGNANCIES. Ferrazzani S, Moresi S, Garofalo S, Degennaro VA, Salvi S, Di Pasquo E, Del Sordo G, De Carolis S. Pregnancy Hypertens. 2012 Jul;2 (3):257-8
  8. HYPERTENSIVE DISORDERS IN PREGNANT WOMEN AFFECTED BY TYPE 1 DIABETES. De Carolis S, Martino C, di Pasquo E, Santucci S, Stifani F, Macri’ F, Degennaro V, Ferrazzani S. Pregnancy Hypertens. 2011 Jul-Oct;1 (3-4):288-9
  9. THE ROLE OF HEPARIN IN THE PREVENTION OF PREECLAMPSIA. Ferrazzani S, Degennaro V, Moresi S, Botta A, Santucci S, Salvi S, De Carolis S. Pregnancy Hypertens. 2011 Jul-Oct;1 (3-4):245
  10. ZINC THERAPY IN NEUROLOGICALWILSON’S DISEASE DURING PREGNANCY: CASE REPORT AND REVIEW OF THE LITERATURE. Bianchi ML, Masciullo M, Modoni A, De Carolis S, Silvestri G EUROPEAN JOURNAL OF NEUROLOGY, vol. 258, p. 163-164, ISSN: 1351-5101 (2011)
  11. EUROPEAN REGISTRY OF BABIES BORN TO MOTHERS WITH ANTIPHOSPHOLIPID SYNDROME. Mekinian A, Loire-Berson P, Lachassinne E, Nicaise-Roland, P, Vicaut E, Stirnemann J, Chollet-Martin S, Motta M, Tincani A, Boinot C, Pourrat O, Avcin, T, Tomsik R, Benbara A, De Carolis S, Rovere P, Carbillon L, Aurousseau MH, Boffa MC, Fain O ARTHRITIS AND RHEUMATISM, vol. 63, p. S284, ISSN: 1529-0131. (2011)
  12. Santucci S, Salvi S, Degennaro VA, Lecca A, Cardinali S, Tarsia V, Fischetti C, De Carolis S, Ferrazzani S (2009). TWIN PREGNANCY AND PSYCHOLOGICAL ASSISTANCE: PRELIMINARY DATA OF A PROSPECTIVE STUDY. THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, ISSN: 1476-7058
  13. NEONATAL OUTCOME IN HYPERTENSIVE DISORDERS OF PREGNANCY: AN ITALIAN SAMPLE.Ferrazzani S, Garofalo S, Luciano R, De Carolis S, Martino C, Botta A, de Gennaro V, Salvi S, Caruso A (2008) HYPERTENSION IN PREGNANCY, vol. 27, p. 678, ISSN: 1064-1955
  14. CLINICAL FOLLOW UP OF BABIES BORN TO MOTHERS WITH APS. Lachassinne E, Motta M, De Carolis MP, Besnier S, Avcin T, Aurousseau MH, Carbillon L, Fain O,
  15. Nicaise P, Le Toumelin P, Biasini-Rebaioli C, Lojacono A, De Carolis S, Botta A, Boinot C, Derenne S, Schlegel N, Tincani A, Uzan M, Laurian Y, Gaudelus J, Boffa MC (2007). RID E-7608-2010. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol. 25, p. 156, ISSN: 0392-856X
  16. FALSE POSITIVITA’ DELLE IGM PER CITOMEGALOVIRUS IN GRAVIDANZE COMPLICATE DA MALATTIE AUTOIMMUNI. De Carolis S, Botta A., Santucci S., Martino C., Salvi S., De Gennaro V., Ferrazzani S. (2008). In: Suppl. Giorn. It. Ost. Gin. Vol. XXX n. 6-7/2008; 508.
  17. IMMUNOLOGICAL FOLLOW UP OF BABIES BORN TO MOTHERS WITH APS Aurousseau MH, Nicaise R, Lachassinne E, Boinot C, Biasini-Rebaioli C, De Carolis S, Botta A, Avcin T, Motta M, Carbillon L, Fain O, Le Toumelin P, Besnier S, Lojacono A, De Carolis MP, Schlegel N, Derenne S, Uzan M, Gaudelus J, Laurian Y, Tincani A, Boffa MC (2007). RID E-7608-2010. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, Vol. 25, p. 156-157, ISSN: 0392-856X
  18. FALSE POSITIVE IGM ANTIBODY TEST FOR CYTOMEGALOVIRUS IN PREGNANT WOMEN WITH AUTOIMMUNE DISEASE. De Carolis S, Botta A, Santucci S, Martino C, Garofalo S, Fatigante G, Puccio R, Alessio A, Ferrazzani S (2007). CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol. 25, p. 155-156, ISSN: 0392-856X
  19. UTERINE ARTERY VELOCITY WAVEFORMS AS PREDICTORS OF PREGNANCY OUTCOME IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS). De Carolis S, Botta A, Santucci S, Garofalo S, Martino L, Fatigante G, Caforio L, Caruso A (2007). THROMBOSIS RESEARCH, vol. 119, p. S102, ISSN: 0049-3848, doi: 10.1016/S0049-3848(07)70066-X
  20. INHERITED THROMBOPHILIA: TREATMENT DURING PREGNANCY. De Carolis S, Ferrazzani S, De Stefano V, Garofalo S, Fatigante G, Rossi E, Leone G, Caruso A (2007). THROMBOSIS RESEARCH, vol. 119, p. S102, ISSN: 0049-3848, doi: 10.1016/S0049-3848(07)70066-X
  21. FALSE-POSITIVE IGM ANTIBODY TESTS FOR TORCH IN PREGNANT WOMEN WITH SLE OR APS.De Carolis S, Martino C, Botta A, Garofalo S, Fatigante G, Ferrazzani S, Caruso A (2005). IMMUNOBIOLOGY, ISSN: 0171-2985
  22. PREVENT OF AV BLOCK BY STEROIDS DURING PREGNANCY: A CASE REPORT.De Carolis S, Botta A, Grimolizzi F, Martino C, Ferrazzani S, Caruso A (2004). LUPUS, ISSN: 0961-2033
  23. SYSTEMIC LUPUS ERYTHEMATOSUS IN PREGNANCY: MATERNAL HYPERTENSION ATCONCEPTION AS PREDICTOR FACTOR FOR POOR PREGNANCY OUTCOME. De Carolis S, Botta A, Martino C, Tomei C, Garofalo S, Ferrazzani S, Caruso A LUPUS, (2004). ISSN: 0961-2033
  24. METABOLIC CHARACTERISTICS IN PREGNANCIES COMPLICATED BY HYPERTENSION AND PREECLAMPSIA. HYPERTENSION IN PREGNANCY, Ferrazzani S, Paradisi G, De Carolis S, Lucchese A, Lanzone A, Carducci B, Caruso A (2000). ISSN: 1064-1955
  25. HIGH PREVALENCE OF HELICOBACTER PYLORI INFECTION IN RECURRENT SPONTANEOUS ABORTION. Torre ES, Gasbarrini A, Trivellini C, De Carolis S, Camilli FM, Ojetti, V, Franceschi F, Candelli M,
  26. Armuzzi A, Gabrielli M, Danese S, Canducci F (1999). GASTROENTEROLOGY, vol. 116, p. A336, ISSN: 0892-1601
  27. HIGH PREVALENCE OF INFECTION BY H.PYLORI CYTOTOXIC TYPE I STRAINS IN RECURRENT SPONTANEOUS ABORTION. Torre ES, Gasbarrini A, Trivellini C, De Carolis S, Camilli FM, Ojetti V, Candelli M, Franceschi F,
  28. Armuzzi A, Danese S, Pola P, Caruso A, Gasbarrini G. (1999).
  29. GUT, vol. 45, p. A88, ISSN:0017-5749
  30. INSULIN SECRECTION AND RESISTANCE IN HYPERTENSIVE PREGNANCIES . HYPERTENSION IN PREGNANCY, Caruso A, Paradisi G, Ferrazzani S, De Carolis S, Lucchese A, Moretti S (1997).ISSN: 1064-1955
  31. TWIN PREGNANCY AS MODEL OF RELATIVE PLACENTAL INSUFFICIENCY WHICH COULD REVEAL WOMEN’S SUSCEPTIBILITY FOR PREECLAMPSIA. De Carolis S, Marola A, Carducci B, Mancuso S (1997). HYPERTENSION IN PREGNANCY, ISSN: 1064-1955
  32. TOTAL PARENTAL NUTRITION IN PREGNANCY. DEVELOPMENTAL. De Carolis S, Trivellini C, Mastromarino C, Pompei A, Ferrazzani S, Carducci B, De Saantis L, Caruso A (1994). BRAIN DYSFUNCTION, ISSN: 1019-5815
  33. LONGITUDINAL ULTRASOUND EVALUATION OF FETAL GROWTH DURING TOTAL PARENTAL NUTRITION IN PREGNANCY. De Carolis S, Mastromarino C, Trivellini C, Pompei A, De Santis M, Ferrazzani S, Caruso A (1994). DEVELOPMENTAL BRAIN DYSFUNCTION, ISSN: 1019-5815
  34. TWIN PREGNANCY: A RELATIVE PLACENTAL INSUFFICIENCY MODEL THAT COULD REVEAL WOMEN’S LIABILITY FOR PREECLAMPSIA. Ferrazzani S, De Carolis S, Merola A, Caruso A, Mancuso S (1994). ISRAEL JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol. 5, p. 28-29, ISSN: 0792-4569
  35. COLOR DOPPLER ULTRASOUND OF UTERINE ARTERIES IN PREGNANCIES WITH LUPUS ERYTHEMATOSUS SYSTEMICUS AND/OR ANTIPHOSPHOLIPID ANTIBODIES. De Carolis S, Ferrazzani S, Rizzo G, Arduini D, Testa Aac, Castaldo F, De Santis L, Caruso A (1993). HYPERTENSION IN PREGNANCY, ISSN: 1064-1955
  36. THE DURATION OF HYPERTENSION IN PUERPERIUM OF PREECLAMPTIC WOMEN RELATES TO FETAL GROWTH, RENAL IMPAIRMENT AND PROTEINURIA. Ferrazzani S, Caruso A, De Carolis S, Pomini F, Testa Ac (1993). HYPERTENSION IN PREGNANCY, ISSN: 1064-1955
  37. PREDICTION OF PREECLAMPSIA BY DOPPLER UTERINE FLOW WAVEFORMS. Caruso A, Ferrazzani S, De Carolis S, Rizzo G, Testa Ac, Pometti A (1992). AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol. 166, p. 300, ISSN: 0002-9378
  38. OBSTETRICC COMPLICATIONS IN 23 PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES. De Carolis S, Valesini G, Romano D, Paradisi G, Ferrazzani S, Carducci B, Carusso A (1992). LUPUS, ISSN: 0961-2033
  39. POLYCISTIc OVARY(PCO): A RISK FACTOR FOR GESTATIONAL DIABETES(GD)? Caruso A, Di Simone N, Lanzone A, De Carolis S, Mancuso S (1992). AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, ISSN: 0002-9378
  40. COLOR DOPPLER ULTRASOUND OF UTERINE ARTERIES IN PREGNANCIES WITH ANTIPHOPHOLIPID SYNDROME. De Carolis S, Ferrazzani S, Valesini G, De Santis L, Carducci B, Paradisi G, Romano D, Caruso A (1992). EOS, ISSN: 0392-6699
  41. ANTICARDIOLIPIN ANTIBODIES AND PREGNANCY WASTAGE De Carolis S, Ferrazzani S, Valesini G, De Santis L, Carducci B, Paradisi G, Romano D, Arnò E, Caruso A. EOS, vol. 12, ISSN: 0392-6699 (1992)
  42. LOW-DOSE ASPIRIN AND VASCULAR REACTIVITY. CLINICAL AND EXPERIMENTAL HYPERTENSION. Caruso A, Ferrazzani S, De Carolis S, Tocci A, Pometti A, Halberg F, Cornellissen G PART B, HYPERTENSION IN PREGNANCY, vol. B10, ISSN: 0730-0085 (1991)
  43. VASCULAR REACTIVITY AND POSSIBLE PREVENTION OF GESTAATIONAL HYPERTENSION. Caruso A, Ferrazzani S, De Carolis S, Pomini F, Testa Ac, Romano D GYNECOLOGICAL ENDOCRINOLOGY, vol. 5, p. 19, ISSN: 0951-3590 (1991).
  44. OBSTETRIC MANAGEMENT IN PREGNANCIES WITH ANTIPHOSPHOLIPID ANTIBODIES. Caruso A, De Carolis S, Ferrazzani S, Paradisi G, Romano D, Mancuso S INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, ISSN: 0020-7292 (1991).
  45. PREVALENCE OF ANTICARDIOLIPID ANTIBODIES IN 205 SELECTED WOMEN. Caruso A, De Carolis S, Ferrazzani S, Romano D, Valesini G, Arno’ E, Mancuso S. JOURNAL OF PERINATAL MEDICINE, ISSN: 0300-5577 (1991).
  46. CASE REPORT: NEONATAL NECROTIZING ENTEROCLITIS AND MATENAL TREATMENT WITH CAPTOPRIL De Carolis Mp, Muzii U, Romagnoli C, De Carolis S, Ferrazzani S, Caruso A (1991). CLINICAL AND EXPERIMENTAL HYPERTENSION. PART B, HYPERTENSION IN PREGNANCY, vol. b10, p. 179-272, ISSN: 0730-0085
  47. PREVALENCE OF ANTIPHOSPHOLIPID ANTIBODIES IN 164 SELECTED WOMEN. De Carolis S, Valesini G, Ferrazzani S, De Stefano V, Falco M, Pometti A, Caruso A (1990). CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol. 8, p. 219, ISSN: 0392-856X
  48. CHRONOBIOLOGIC APPROACH TO PREGNANCY-INDUCED HYPERTENSION AND INDIVIDUALIZED ASSESSMENT OF LOW-DOSE ASPIRIN FOR PRE-ECLAMPSIA PREVENTION. Ferrazzani S, Cornelissen G, Caruso A, De Carolis S, Hillman D, Di Giglio R, Vercillo Martino I, Pometti A, Tocci A Kato J, Tamura K, Halberg F (1990). PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH, ISSN: 0361-7742
  49. CHRONOBIOLOGIC APPROACH TO GESTATIONAL HYPERTENSION. Caruso A, Cornelissen G, Halberg F, Hillman D, Ferrazzani S, De Carolis S, Di Giglio R, Vercillo Martino I, Pometti A (1989). CHRONOBIOLOGIA, ISSN: 0390-0037
  50. LOW-DOSE ASPIRIN, THE ANGIOTENSIN SENSIVITY TEST (AST9 AND BLOOD PRESSURE IN PREGNANCY: CHRONOBIOLOGIC GROUP ASSESSMENT. De Carolis S, Caruso A, Ferrazzani S, Di Giglio R, Vercillo Martino I, Pometti A (1989). CHRONOBIOLOGIA, ISSN: 0390-0037
  51. INDIVIDUALIZED CHRONOBIOLOGIC ASSESSMENT OF LOW DOSE ASPIRIN FOR PRE-ECLAMSPIA PREVENTION. Ferrazzani S, Caruso A, De Carolis S, Di Giglio R, Vercillo Martino I, Pometti A, Cornellissen G, Hillman D Halberg F (1989). CHRONOBIOLOGIA, ISSN: 0390-0037
  52. ANTICARDIOLIPIN ANTIBODIES IN PREGNANT WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS OR LUPUS LIKE ANTICOAUGULANT. De Carolis S, Caruso A, Valesini G, De Stefano V, Leone G, Falco M, Ferrazzani S, Mancuso S (1988). CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol. 6, p. 23, ISSN: 0392-856X
  53. PLACENTAL DERIVED PGI2 INHIBITS CORD PLATELET FUNCTION: POSSIBLE ROLE OG PGI IN THE TRANSIENT HYPOREACTIVITY OF NEWBORN PLATELETS. Landolfi R, De Cristofaro R, De Carolis S, Ciabattoni G, Bizzi B (1987). THROMBOSIS AND HAEMOSTASIS, ISSN: 0340-6245
  54. IMMUNOGLOBULINS IN PREGNANCIES COMPLICATED BY HYPERTENSIVE DISEASE. Ferrazzani S, De Carolis S, Farinacci R, Pieroni A, Ciccarelli MG, Plotti G, Moneta E (1987). CLINICAL AND EXPERIMENTAL HYPERTENSION. PART B, HYPERTENSION IN PREGNANCY, vol. B6, p. 132, ISSN: 0730-0085

Se non trovi la risposta al tuo quesito, fai la tua domanda ai nostri specialisti. Ti risponderemo prima possibile. Fai una domanda all’esperto

Fonti / Bibliografia

Articoli di Dottoressa Sara De Carolis

Paura di abortire

Se una gravidanza inizia dopo un aborto spontaneo, conviene recarrsi subito dal ginecologo per farsi seguire in modo adeguato.  »

Maschio secondo il test del Dna fetale, invece è una bambina

In caso di discrepanze per quanto riguarda il sesso del bambino tra quanto segnala il risultato dell'indagine sul Dna fetale e l'ecografia, possono fare chiarezza altri controlli ecografici.   »

Dolori al seno: colpa dell’allattamento prolungato?

Si può escludere che la mastodinia sia in relazione con l'allattamento concluso ormai da un anno.  »

Fare o non fare il test per la ricerca della listeria?

Dopo aver tenuto un comportamento a rischio, come lo è assumere un formaggio prodotto con latte non pastorizzato, è bene escludere la listeriosi effettuando lo specifico test.   »

Paura della listeriosi

Durante la gravidanza, in caso di assunzione di un alimento potenzialmente implicato nel rischio di trasmissione della listeriosi, per escludere che sia avvenuto il contagio è prudente effettuare lo specifico test anche in assenza di sintomi.   »

Perdite dopo la “conizzazione”

In seguito all'intervento di conizzazione le perdite di sangue possono protrarsi anche per circa un mese.  »

Incinta subito dopo una IVG?

Dopo un'interruzione volontaria di gravidanza, è possibile rimanere nuovamente incinta se non si prendono precauzioni contraccettive efficaci.   »

Un figlio a 40: c’è la possibilità che vada tutto bene?

A 40 anni di età ci sono più rischi in relazione a una gravidanza, tuttavia è possibile, anche grazie ai controlli da effettuare prima e durante, che tutto si concluda nel migliore dei modi.  »

Gravidanza e stanchezza che non passa

Un malfunzionamento della tiroide si esprime anche con un affaticamento che non diminuisce mai: rivolgersi tempestivamente a un endocrinologo è d'obbligo, specialmente se si è in attesa di un bambino.   »

HIV in gravidanza

E' senz'altro possibile che una donna sieropositiva possa portare a termine la gravidanza nel migliore dei modi, dando alla luce un bimbo sano. E' ovvio però che per ridurre al massimo ogni rischio deve attenersi alle indicazioni del ginecologo e dell'infettivologo, anche per quanto riguarda la cadenza...  »

Pagina 1 di 2
Le informazioni contenute in questo sito non intendono e non devono in alcun modo sostituire il rapporto diretto fra professionisti della salute e l’utente. È pertanto opportuno consultare sempre il proprio medico curante e/o specialisti.

Gli Specialisti rispondono
Le domande della settimana

Coronavirus: è pericoloso per la fertilità maschile?

30/03/2020 Gli Specialisti Rispondono di Dottor Mario Mancini

Non c'è alcuna evidenza scientifica a supporto dell'ipotesi che il SARS-CoV-2 causi infertilità nell'uomo: si tratta dunque di una bufala.   »

Va bene questo valore delle beta?

30/03/2020 Gli Specialisti Rispondono di Dottoressa Elisa Valmori

In sesta settimana, un valore dell'ormone beta-hCG superiore a 10.000 esprime che la gravidanza è in evoluzione, quindi è un ottimo segno.   »

Bimba di tre anni che fa sempre le stesse domande

26/03/2020 Gli Specialisti Rispondono di Dott. Leonardo Zoccante

E' normale che un bambino di tre anni chieda e richieda spesso le stesse cose: le risposte che ottiene (e che ci devono sempre essere) gli servono per consolidare le sue conoscenze.   »

Fai la tua domanda agli specialisti